CREBBP is a Major Prognostic Biomarker for Relapse in Childhood B-cell Acute Lymphoblastic Leukemia: A National Study of Unselected Cohort
By:
Authors
E Krstevska Bozhinovikj
Center for Biomolecular Pharmaceutical Analyses, Faculty of Pharmacy, University Ss. Cyril and Methodius in Skopje, Skopje, N. Macedonia
N Matevska-Geshkovska
Center for Biomolecular Pharmaceutical Analyses, Faculty of Pharmacy, University Ss. Cyril and Methodius in Skopje, Skopje, N. Macedonia
M Staninova Stojovska
Center for Biomolecular Pharmaceutical Analyses, Faculty of Pharmacy, University Ss. Cyril and Methodius in Skopje, Skopje, N. Macedonia
E Gjorgievska
Center for Biomolecular Pharmaceutical Analyses, Faculty of Pharmacy, University Ss. Cyril and Methodius in Skopje, Skopje, N. Macedonia
A Jovanovska
University Clinic for Pediatric diseases, Faculty of Medicine, University Ss. Cyril and Methodius in Skopje, Skopje, N. Macedonia
S Kocheva
University Clinic for Pediatric diseases, Faculty of Medicine, University Ss. Cyril and Methodius in Skopje, Skopje, N. Macedonia
A Dimovski
Center for Biomolecular Pharmaceutical Analyses, Faculty of Pharmacy, University Ss. Cyril and Methodius in Skopje, Skopje, N. Macedonia
Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, Macedonian Academy of Sciences and Arts, Skopje, N. Macedonia
DOI: https://doi.org/10.2478/bjmg-2024-0020 | Journal eISSN: 2199-5761
Language: English
Page range: 5 - 12
Published on: Mar 6, 2025
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Related subjects:
© 2025 E Krstevska Bozhinovikj, N Matevska-Geshkovska, M Staninova Stojovska, E Gjorgievska, A Jovanovska, S Kocheva, A Dimovski, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.